New hope for genetic ALS? old drug gets first human test
NCT ID NCT07204977
Summary
This study is testing if a drug called acamprosate is safe and might help slow the progression of ALS (amyotrophic lateral sclerosis) in people who have a specific genetic change (C9orf72 mutation). It involves 30 participants who will take the drug for 24 weeks while researchers monitor their health and symptoms. The main goal is to check for side effects, but researchers will also look for any signs that the drug might help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.